PhaseBio Pharmaceuticals, Inc. (PHAS)
Net Income
-$16.78M
Quarterly · Period ending: · USD
PHAS Net Income
Latest reported-$16.78Mperiod ending
Latest reported-$16.78Mperiod ending
PHAS Quarterly Net Income (-$2.56M → -$16.78M)
Quarterly net income
High-resolution chart · PNG
PHAS net income history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Income (USD) |
|---|---|
| -16,781,000 | |
| -11,289,000 | |
| 87,829,929 | |
| -31,924,000 | |
| -28,679,000 | |
| -27,358,000 | |
| -30,375,000 | |
| -25,143,000 | |
| -28,142,000 | |
| -14,905,000 | |
| -11,331,000 | |
| -11,391,000 | |
| -9,232,000 | |
| -7,293,000 | |
| -4,868,000 | |
| -7,901,000 | |
| -6,674,000 | |
| -4,403,000 | |
| -2,535,000 | |
| -2,560,000 |